Health

Medlinker's MedGPT Performs 96% As Well As Top Human Doctors

In a Livestreamed Real-World Assessment, MedGPT's AI Doctors Rival Diagnostic Accuracy ofChina's Leading Doctors BEIJING, July 22, 2023 /PRNewswire/ -- Medlinker, a leading digital healthcare company inChina, undertook a real world comparison of AI doctors accessible through its MedGPT service ...

2023-07-22 12:30 3378

YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

GAITHERSBURG, Md., July 21, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-07-22 04:30 4368

Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND

SHANGHAI, July 21, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 7MW3711 for advanced malignant solid tumor was approved by the National Medical Products Administration (NMPA). 7MW3711...

2023-07-22 00:00 4421

SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979

NANJING, China, July 21, 2023 /PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharmaceutical company in immunocytokines with full-set of capabilities from discovery to commercialization, announced that IBB0979 (B7H3-IL10 immunocytokine), a potential first...

2023-07-21 22:51 2954

GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent

* Striving to further expand its territory to Africa and the Middle East from Southeast Asia and Latin America * "Will create synergy between international procurement market and private markets of individual countries so as to boost sales and profitability" YONGIN, South Korea, July 21, 2023...

2023-07-21 16:47 2007

Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference

BEIJING and SHANGHAI and BOSTON, July 20, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, is pleased to announce today that the company will present its clinical results in the form of Proffered Paper presentation at the 2023 Europ...

2023-07-21 10:19 1894

US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer

SEONGNAM, South Korea, July 20, 2023 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced onJuly 19 that the US FDA had granted an orphan drug designation for small cell lung cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug under development. SNB-101 is the world...

2023-07-21 08:15 1910

Angel Yeast Highlights Sustainable Protein and Natural Taste Solutions at IFT FIRST 2023

CHICAGO, July 20, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), a premier global yeast company, showcased its sustainable yeast protein and compound seasoning solutions at the annual expo of the Institute of Food Technologists ("IFT FIRST 2023"), inChicago, that took...

2023-07-20 20:00 2425

BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial

WUXI, China, July 19, 2023 /PRNewswire/ -- BioCity Biopharma, a clinical-stage biopharmaceutical company committed to developing novel and highly differentiated, modality-independent therapeutics for cancer and autoimmune disorders, today announced the dosing of the first patient in a Phase 1a/1b...

2023-07-20 10:41 1967

Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech

ZHUHAI, China, July 19, 2023 /PRNewswire/ -- Biotheus Inc. ("Biotheus"), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and inflammatory diseases, announced today that it has entered into a strategic research collaboration, option and worldwi...

2023-07-20 09:01 1940

Origin Agritech Secures RMB 2 Million Grant for Building Germplasm Bank in Xinjiang

BEIJING, July 19, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it has been awarded a grant ofRMB 2 million (approximately $280,000 USD) from the Xinjiang government. The grant aims to support Origin's...

2023-07-19 23:54 5362

VARON Launches the Game-changer in the Field--New VP Series Portable Oxygen Concentrator with Increased Mobility and Convenience

SEATTLE, July 19, 2023 /PRNewswire/ -- VARON, a leading oxygen concentrator manufacturer, is proud to announce the launch of a new member of the VP series --VP-2 . This portable oxygen concentrat...

2023-07-19 22:30 1678

JX Luxventure announces a new Artificial Intelligence initiative: USD1,000,000 Agreement with Tianjin Baixing Pharmaceutical Wholesale Co., Ltd. in connection with incorporating ChatGPT type technology for ERP platform

HAIKOU, China, July 19, 2023 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: JXJT) (the "Company"), a company that engages in tourism with business segments covering tourism, tourism duty-free cross-border merchandise and tourism technology solutions, today announced that onJuly 17, 2023, its subs...

2023-07-19 21:36 6845

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

SUZHOU, China, July 19, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has initiated the long-term safety trial (the "Long-term ...

2023-07-19 21:03 2125

Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication

SHANGHAI , July 18, 2023 /PRNewswire/ -- The product of Fosun Kite Biotechnology Co., Ltd., jointly established by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Kite Pharma ofthe United States (trade name: Yikaida®) for the treatment of adult large B-cell lymphoma (r/r LBCL) ("this new ind...

2023-07-19 10:42 1792

Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

SHANGHAI, July 18, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 9MW2921 for advanced solid tumor was approved by the National Medical Products Administration (NMPA). 9MW2921 is dev...

2023-07-19 00:00 2747

Neurophet to unveil brain image analysis technology related to treatment of Alzheimer's disease at AAIC 2023

- New brain image analysis solution for Alzheimer's disease treatment is planned to be commercialized along with the release of treatment - In discussion with global big pharma companies for collaboration at AAIC SEOUL, South Korea, July 18, 2023 /PRNewswire/ -- Neurophet, an artificial in...

2023-07-18 21:00 2528

Baird Medical Obtains NMPA Approval of Class III Registered Microwave Ablation Needle for Thyroid Nodules

GUANGZHOU, China, July 18, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, announced today that the Company's independently developed and produced disposable MWA ...

2023-07-18 20:30 1843

Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions

* PreFluid is a leader in integrated fluid solutions * PreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental industries worldwide SHANGHAI, July 18, 2023 /PRNewswire/ -- Duoning Biotechnology Co., Ltd. ("Duoning Biotech") has used Shanghai Duoning...

2023-07-18 20:00 2322

Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

INCHEON, South Korea, July 18, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social and Governance (ESG) Report. The annual report outlines the company's progress toward its sustain...

2023-07-18 19:00 1853
1 ... 84858687888990 ... 280